Condition

Non Hodgkin Lymphoma (NHL) clinical trials and research

• 7Clinical trials
• 5Countries

Newest Non Hodgkin Lymphoma (NHL) clinical trials

All recruiting trials (7)

• ALA-101 in CD19+ blood cancers

  A small early-phase test to see if ALA-101, an off-the-shelf CAR-iNKT cell therapy, is safe and potentially effective in adults with CD19-positive NHL or leukemia.

  Recruiting Phase 1 Arovella Therapeutics Ltd · Sydney, New South Wales and 4 other locations · NCT07518329

• Radiation, Vancomycin, and CAR-T for B-Cell Lymphoma

  This trial tests if giving radiation and the antibiotic vancomycin before CAR-T cell therapy is feasible for adults with large B-cell lymphomas.

  Recruiting Phase 1 Abramson Cancer Center at Penn Medicine · Philadelphia, Pennsylvania · NCT07478848

• LV009 infusion for relapsed/refractory CD19-positive blood cancers

  This early-phase study will test whether LV009 infusion is safe and how it behaves in adults with relapsed or refractory CD19-positive blood cancers such as NHL or ALL.

  Recruiting Early Phase 1 PersonGen BioTherapeutics (Suzhou) Co., Ltd. · Hefei, Anhui · NCT07312630

• Poseltinib (NB02) alone for relapsed or refractory non-Hodgkin lymphoma

  This trial tests oral poseltinib (NB02) to see if it is safe and shows anti-lymphoma activity in adults 19–80 with relapsed or refractory follicular, mantle cell, or marginal zone lymphoma after at least two prior treatments.

  Recruiting at 6 sites Phase 1 NOBO Medicine · Hwasun and 5 other locations · NCT07114367

• OriV508 injection for relapsed or refractory multiple myeloma and aggressive B‑cell lymphoma

  We will try OriV508, an in‑body lentiviral therapy carrying a BCMA/CD19 dual‑target CAR, in adults whose multiple myeloma or aggressive B‑cell lymphoma has returned or not responded to prior treatments.

  Recruiting Early Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07101705

• CAR-T cell therapy for patients with relapsed B cell cancers

  This study is testing a new CAR-T cell therapy for adults with relapsed B cell cancers to see how well it works and if different manufacturing methods make a difference in treatment outcomes.

  Recruiting Phase 1/2 Medical College of Wisconsin · Milwaukee, Wisconsin · NCT04186520

• Monitoring and improving treatment for non-Hodgkin lymphoma patients in the Czech Republic

  This study is trying to gather and analyze information about non-Hodgkin lymphoma patients in the Czech Republic to improve their diagnosis and treatment.

  Recruiting Czech Lymphoma Study Group · Prague · NCT03199066

Related topics

Quick answers

How many Non Hodgkin Lymphoma (NHL) clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (2 trials), China (2 trials), Australia (1 trial), South Korea (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Early Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →